Variant report

Variant	rs10085570
Chromosome Location	chr7:27151188-27151189
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	JUN	chr7:27150845-27151223	HUVEC	blood vessel:	n/a	chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
2	TCF12	chr7:27150131-27151486	A549	lung:	n/a	n/a
3	EP300	chr7:27150706-27151317	A549	lung:	n/a	chr7:27151029-27151038
4	POLR2A	chr7:27150903-27151220	HUVEC	blood vessel:	n/a	n/a
5	MYC	chr7:27150898-27151210	HUVEC	blood vessel:	n/a	n/a
6	SP1	chr7:27150256-27151280	A549	lung:	n/a	n/a
7	FOSL2	chr7:27150645-27151460	A549	lung:	n/a	chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
8	POLR2A	chr7:27150935-27151333	MCF10A-Er-Src	breast:	n/a	n/a
9	POLR2A	chr7:27150114-27151949	PANC-1	pancreas:	n/a	n/a
10	POLR2A	chr7:27150078-27151774	IMR90	lung:	n/a	n/a
11	FOS	chr7:27150855-27151455	MCF10A-Er-Src	breast:	n/a	chr7:27151027-27151038 chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
12	GATA3	chr7:27150141-27151376	A549	lung:	n/a	chr7:27151202-27151212
13	JUND	chr7:27150773-27151219	A549	lung:	n/a	chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
14	E2F4	chr7:27150859-27151218	MCF10A-Er-Src	breast:	n/a	n/a
15	FOSL1	chr7:27150728-27151311	HCT-116	colon:	n/a	chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
16	JUND	chr7:27150698-27151417	HCT-116	colon:	n/a	chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
17	BCL3	chr7:27151044-27151749	A549	lung:	n/a	n/a
18	STAT3	chr7:27150357-27152662	MCF10A-Er-Src	breast:	n/a	chr7:27151922-27151931 chr7:27151228-27151239 chr7:27151280-27151291 chr7:27152166-27152173 chr7:27151282-27151290 chr7:27151921-27151930
19	BCL3	chr7:27150103-27151323	A549	lung:	n/a	chr7:27150501-27150514
20	STAT3	chr7:27150908-27151627	MCF10A-Er-Src	breast:	n/a	chr7:27151228-27151239 chr7:27151280-27151291 chr7:27151282-27151290
21	MAZ	chr7:27149150-27151495	IMR90	lung:	n/a	chr7:27150339-27150348 chr7:27150337-27150350 chr7:27150339-27150348 chr7:27150339-27150348 chr7:27150334-27150353
22	POLR2A	chr7:27150168-27151691	PANC-1	pancreas:	n/a	n/a
23	MAFK	chr7:27150290-27151203	IMR90	lung:	n/a	chr7:27150475-27150486 chr7:27150470-27150486 chr7:27150475-27150486 chr7:27150473-27150487
24	FOS	chr7:27150470-27151625	MCF10A-Er-Src	breast:	n/a	chr7:27151027-27151038 chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
25	STAT3	chr7:27150361-27152505	MCF10A-Er-Src	breast:	n/a	chr7:27151922-27151931 chr7:27151228-27151239 chr7:27151280-27151291 chr7:27152166-27152173 chr7:27151282-27151290 chr7:27151921-27151930
26	FOS	chr7:27150453-27151615	MCF10A-Er-Src	breast:	n/a	chr7:27151027-27151038 chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
27	MAX	chr7:27150162-27151385	A549	lung:	n/a	chr7:27150339-27150348 chr7:27150337-27150350 chr7:27150339-27150348 chr7:27150339-27150348 chr7:27150334-27150353
28	MYC	chr7:27150878-27151201	MCF10A-Er-Src	breast:	n/a	n/a
29	MYC	chr7:27150383-27151256	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr7:27150845-27151218	MCF10A-Er-Src	breast:	n/a	chr7:27151027-27151038 chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
31	ZNF263	chr7:27150256-27151757	HEK293-T-REx	kidney:	n/a	n/a
32	STAT3	chr7:27150396-27152319	MCF10A-Er-Src	breast:	n/a	chr7:27151922-27151931 chr7:27151228-27151239 chr7:27151280-27151291 chr7:27152166-27152173 chr7:27151282-27151290 chr7:27151921-27151930
33	EP300	chr7:27150318-27151393	A549	lung:	n/a	chr7:27150505-27150521 chr7:27151029-27151038
34	GATA2	chr7:27150633-27151576	HUVEC	blood vessel:	n/a	chr7:27151202-27151212
35	SP1	chr7:27150270-27151322	A549	lung:	n/a	n/a
36	CHD1	chr7:27134717-27152399	IMR90	lung:	n/a	chr7:27141647-27141657
37	CEBPB	chr7:27150828-27151220	IMR90	lung:	n/a	n/a
38	STAT3	chr7:27150361-27152501	MCF10A-Er-Src	breast:	n/a	chr7:27151922-27151931 chr7:27151228-27151239 chr7:27151280-27151291 chr7:27152166-27152173 chr7:27151282-27151290 chr7:27151921-27151930
39	FOS	chr7:27150632-27151578	HUVEC	blood vessel:	n/a	chr7:27151027-27151038 chr7:27151029-27151036 chr7:27151181-27151195 chr7:27151029-27151038
40	POLR2A	chr7:27150697-27151735	HUVEC	blood vessel:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:26902820..26904709-chr7:27149740..27152341,2	MCF-7	breast:
2	chr7:27150209..27152562-chr7:27153238..27155636,2	K562	blood:
3	7:27143270-27156413..7:27162022-27164727	H1-hESC	embryonic stem cell:	embryo
4	chr7:27144721..27146967-chr7:27150748..27152379,2	K562	blood:
5	chr7:27150791..27152361-chr7:27154839..27156981,2	MCF-7	breast:

Variant related genes	Relation type
HOXA-AS2	TF binding region
ENSG00000105997	Chromatin interaction
ENSG00000253552	Chromatin interaction
ENSG00000005020	Chromatin interaction

Extended variants
information (count: 93 )
Associated
traits (count: 4 )

rSNPs within LD-proxies of this variant (count:56)

rs_ID	r²[population]
rs10225507	0.85[ASN][1000 genomes]
rs10238095	0.93[ASN][1000 genomes]
rs10246712	0.92[CEU][hapmap];0.91[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap];0.93[ASN][1000 genomes]
rs11564055	1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[ASN][1000 genomes]
rs11762730	0.92[CEU][hapmap];0.91[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap];0.90[ASN][1000 genomes]
rs11983200	0.84[JPT][hapmap];0.86[ASN][1000 genomes]
rs12530948	0.93[ASN][1000 genomes]
rs12533947	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes]
rs12666919	1.00[CEU][hapmap];0.91[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap];0.84[MEX][hapmap];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs12666926	1.00[CEU][hapmap];0.91[CHB][hapmap];0.92[JPT][hapmap];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs1548497	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.83[MEX][hapmap];1.00[ASN][1000 genomes]
rs1725074	1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[ASN][1000 genomes]
rs17449108	1.00[CHB][hapmap];1.00[JPT][hapmap];0.95[ASN][1000 genomes]
rs17471485	1.00[CHB][hapmap];1.00[JPT][hapmap];0.95[ASN][1000 genomes]
rs17471520	1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes]
rs1801085	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.88[MEX][hapmap];0.97[ASN][1000 genomes]
rs1859166	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes]
rs2107063	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs2285722	0.97[ASN][1000 genomes]
rs2301720	0.92[CEU][hapmap];0.91[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap];0.93[ASN][1000 genomes]
rs2301721	0.85[CEU][hapmap];0.91[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap];0.81[ASN][1000 genomes]
rs2428432	1.00[CHB][hapmap];0.95[CHD][hapmap];1.00[JPT][hapmap];0.93[ASN][1000 genomes]
rs2428433	1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[ASN][1000 genomes]
rs2428434	1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes]
rs2465275	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.93[ASN][1000 genomes]
rs2465276	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.83[MEX][hapmap];0.97[ASN][1000 genomes]
rs3735530	0.85[CEU][hapmap];0.91[CHB][hapmap];0.92[JPT][hapmap];0.93[ASN][1000 genomes]
rs3801320	0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs3807597	1.00[CEU][hapmap];0.81[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap]
rs3823764	0.85[CEU][hapmap];0.91[CHB][hapmap];0.91[CHD][hapmap];0.92[JPT][hapmap];0.86[ASN][1000 genomes]
rs4722657	0.83[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.84[LWK][hapmap];0.94[MEX][hapmap];0.93[MKK][hapmap];0.94[TSI][hapmap];0.86[YRI][hapmap];0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4722659	0.83[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.89[LWK][hapmap];0.94[MEX][hapmap];0.93[MKK][hapmap];0.81[TSI][hapmap];0.86[YRI][hapmap];0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs4722666	0.89[ASN][1000 genomes]
rs61384251	0.97[ASN][1000 genomes]
rs6461985	1.00[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs6461987	1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes]
rs68021164	0.90[ASN][1000 genomes]
rs6948297	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.88[MEX][hapmap];1.00[ASN][1000 genomes]
rs6957209	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.88[MEX][hapmap];0.97[ASN][1000 genomes]
rs6962314	0.98[ASN][1000 genomes]
rs6969780	1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes]
rs6973182	1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes]
rs6976129	0.91[CHB][hapmap];0.91[JPT][hapmap];0.98[ASN][1000 genomes]
rs73071548	1.00[ASN][1000 genomes]
rs73071550	0.81[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs7341470	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[CHD][hapmap];0.93[GIH][hapmap];0.92[JPT][hapmap];0.84[MEX][hapmap];0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs739734	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.88[MEX][hapmap];0.98[ASN][1000 genomes]
rs7798733	1.00[ASN][1000 genomes]
rs7801565	1.00[CHB][hapmap];0.88[JPT][hapmap]
rs7811753	0.83[ASW][hapmap];0.92[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.89[LWK][hapmap];0.94[MEX][hapmap];0.94[MKK][hapmap];0.94[TSI][hapmap];0.86[YRI][hapmap]
rs875898	0.91[CHB][hapmap];0.87[CHD][hapmap];0.92[JPT][hapmap];0.93[ASN][1000 genomes]
rs886339	1.00[CEU][hapmap];0.90[JPT][hapmap];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs929249	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.88[MEX][hapmap];0.98[ASN][1000 genomes]
rs983184	0.85[CEU][hapmap];0.93[ASN][1000 genomes]
rs983185	0.93[ASN][1000 genomes]
rs985652	0.85[CEU][hapmap];0.83[CHB][hapmap];0.90[JPT][hapmap];0.91[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:37 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1025538	chr7:26482342-27376045	Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
2	nsv538805	chr7:26482342-27376045	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
3	nsv1018709	chr7:26990384-27216552	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	140 gene(s)	inside rSNPs	diseases
4	nsv538806	chr7:26990384-27216552	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Genic enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	140 gene(s)	inside rSNPs	diseases
5	nsv887856	chr7:27073731-27297791	Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
6	nsv824038	chr7:27119294-27284522	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
7	nsv887857	chr7:27120689-27229549	Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	176 gene(s)	inside rSNPs	diseases
8	nsv824039	chr7:27121825-27294951	Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
9	nsv824040	chr7:27121870-27295010	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
10	nsv887858	chr7:27127231-27188659	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	57 gene(s)	inside rSNPs	diseases
11	nsv887860	chr7:27127231-27196069	Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
12	nsv887859	chr7:27127231-27196113	Bivalent Enhancer Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
13	nsv887861	chr7:27127231-27206688	Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
14	nsv887862	chr7:27127231-27217359	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	141 gene(s)	inside rSNPs	diseases
15	nsv887863	chr7:27127231-27243106	Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
16	nsv887864	chr7:27127231-27243962	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
17	nsv887865	chr7:27127231-27247279	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
18	nsv887866	chr7:27127231-27248373	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
19	nsv887867	chr7:27127231-27252246	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
20	nsv824041	chr7:27128039-27294951	Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
21	nsv606463	chr7:27135314-27182245	Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
22	nsv887868	chr7:27135314-27202289	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
23	nsv887869	chr7:27135314-27297791	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
24	nsv887870	chr7:27136308-27154737	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
25	nsv887871	chr7:27136308-27179814	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
26	nsv887872	chr7:27136308-27181437	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
27	nsv887873	chr7:27136308-27186495	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
28	nsv887874	chr7:27136308-27196069	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
29	nsv606464	chr7:27138478-27168590	Enhancers ZNF genes & repeats Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	45 gene(s)	inside rSNPs	diseases
30	nsv1020608	chr7:27139892-27324004	Bivalent Enhancer Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
31	nsv538807	chr7:27139892-27324004	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
32	nsv1033316	chr7:27140645-27237951	Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	178 gene(s)	inside rSNPs	diseases
33	nsv606465	chr7:27143757-27229549	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	174 gene(s)	inside rSNPs	diseases
34	nsv606466	chr7:27145024-27197319	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
35	nsv606467	chr7:27145100-27196113	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
36	nsv887875	chr7:27145100-27243962	Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	179 gene(s)	inside rSNPs	diseases
37	nsv532118	chr7:27146920-27354205	Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases

mRNA abundance (count:4)

SNP	Gene	Cis/trans	Tissue	Source
rs10085570	HOXA9	cis	multi-tissue	Pritchard
rs10085570	DFNA5	cis	cerebellum	SCAN
rs10085570	HOTAIRM1	cis	lung	GTEx
rs10085570	HOXA2	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:27145600-27152400	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr7:27145800-27162800	Strong transcription	Primary hematopoietic stem cells short term culture	blood
3	chr7:27146400-27169600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr7:27146800-27159000	Weak transcription	Primary hematopoietic stem cells	blood
5	chr7:27148000-27152600	Weak transcription	Small Intestine	intestine
6	chr7:27149000-27151200	Enhancers	Spleen	Spleen
7	chr7:27149000-27153200	Enhancers	NHDF-Ad	bronchial
8	chr7:27149800-27151600	Enhancers	Sigmoid Colon	Sigmoid Colon
9	chr7:27149800-27153000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr7:27150000-27151400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
11	chr7:27150000-27151800	Flanking Active TSS	HMEC	breast
12	chr7:27150000-27152000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr7:27150000-27153000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
14	chr7:27150000-27153000	Flanking Active TSS	NHEK	skin
15	chr7:27150000-27153400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr7:27150000-27158400	Active TSS	Aorta	Aorta
17	chr7:27150200-27151200	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
18	chr7:27150200-27151200	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
19	chr7:27150200-27151800	Flanking Active TSS	Osteobl	bone
20	chr7:27150400-27151200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr7:27150400-27151200	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr7:27150400-27151400	Flanking Active TSS	Colon Smooth Muscle	Colon
23	chr7:27150400-27151400	Enhancers	Skeletal Muscle Male	skeletal muscle
24	chr7:27150400-27151400	Flanking Active TSS	Stomach Smooth Muscle	stomach
25	chr7:27150400-27151600	Bivalent Enhancer	Fetal Muscle Leg	muscle
26	chr7:27150400-27152200	Flanking Active TSS	A549	lung
27	chr7:27150400-27152600	Enhancers	Muscle Satellite Cultured Cells	--
28	chr7:27150400-27152600	Enhancers	Colonic Mucosa	Colon
29	chr7:27150400-27152600	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr7:27150400-27152600	Enhancers	Hela-S3	cervix
31	chr7:27150400-27152800	Weak transcription	Pancreas	Pancrea
32	chr7:27150400-27153000	Flanking Active TSS	HUVEC	blood vessel
33	chr7:27150400-27154600	Bivalent/Poised TSS	NH-A	brain
34	chr7:27150600-27151200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr7:27150600-27151200	Flanking Active TSS	Fetal Intestine Large	intestine
36	chr7:27150600-27151200	Flanking Active TSS	Stomach Mucosa	stomach
37	chr7:27150600-27151200	Enhancers	HSMM	muscle
38	chr7:27150600-27151400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr7:27150600-27151600	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr7:27150600-27151600	Flanking Bivalent TSS/Enh	Fetal Lung	lung
41	chr7:27150600-27151600	Flanking Active TSS	NHLF	lung
42	chr7:27150800-27151400	Enhancers	HepG2	liver
43	chr7:27150800-27151600	Enhancers	Placenta Amnion	Placenta Amnion
44	chr7:27150800-27151600	Enhancers	Psoas Muscle	Psoas
45	chr7:27150800-27152000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr7:27150800-27152600	Enhancers	Rectal Mucosa Donor 29	rectum
47	chr7:27151000-27151200	Active TSS	Fetal Muscle Trunk	muscle
48	chr7:27151000-27151200	Enhancers	Right Atrium	heart
49	chr7:27151000-27151400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
50	chr7:27151000-27151400	Flanking Active TSS	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links